Plain-language summary
Pneumolysin is a pore-forming toxin made by Streptococcus pneumoniae, the bacterium behind most childhood pneumonia. At doses too low to burst a cell outright, host cells respond by patching their membranes and shedding vesicles that carry the toxin away. What those vesicles do next had been unclear. This study combined molecular dynamics simulation, liposome fusion assays and cell experiments to follow toxin-bearing extracellular vesicles. The simulations showed that pneumolysin sitting in a vesicle membrane uses an exposed helix to engage a target membrane, bending it and thinning the bilayer enough to let water through. Confocal imaging and cryo-electron microscopy confirmed that both the toxin and membrane cholesterol drive vesicle-to-membrane fusion. Profiling the vesicles released by challenged monocytes showed that plasma-membrane-derived microvesicles carried more membrane-bound toxin than smaller vesicles. Microvesicles from monocytes exposed to wild-type bacteria fused with human peripheral blood mononuclear cells and damaged them, an effect that was much weaker with a toxoid mutant. Among those immune cells, CD4+ T cells were the most affected.
Key findings
- Pneumolysin is a cholesterol-dependent pore-forming toxin and a key virulence factor of Streptococcus pneumoniae, the leading cause of pneumonia in children under five.
- Simulation and imaging showed that vesicle-bound pneumolysin uses an exposed helix to bind and deform target membranes, a route distinct from classic pore formation.
- Microvesicles shed from the plasma membrane carried more membrane-bound toxin than smaller extracellular vesicles and fused with human immune cells to deliver it.
- CD4+ T cells showed the highest toxin positivity and cell death among peripheral blood mononuclear cells, while a toxoid mutant caused markedly less damage.
Why this matters for lung repair
This is a microbiology paper about how a bacterial toxin travels inside vesicles, not about therapeutic exosomes. It appears here because it documents the other side of the same biology: vesicle membranes can fuse with target cells and deliver a cargo, which is both the mechanism therapeutic vesicles depend on and a reminder that the composition of a vesicle preparation matters. Nothing in it concerns lung repair, and no part is clinical.
Original abstract
Pneumolysin (PLY) is a cholesterol-dependent pore-forming toxin and a key virulence factor of Streptococcus pneumoniae, the leading cause of pneumonia worldwide in children aged below 5 years. At sublytic toxin doses, host cells shed PLY-laden extracellular vesicles (EVs) during the membrane repair response. However, it remains unclear how these toxin-bearing EVs engage and damage target cell membranes. Here, we combine molecular dynamics simulations, liposome fusion assays and cell-based experiments to elucidate the membrane interaction potential of vesicle-bound PLY. Simulations indicate that EV-embedded PLY uses an exposed helix to bind target cell membranes, inducing pronounced curvature, bilayer thinning and water influx. Liposome fusion assays by 3D confocal imaging and Cryo-EM analysis demonstrate that both PLY and membrane cholesterol promote vesicle-membrane interactions. Characterisation of vesicle subpopulations released from PLY-challenged monocytes by western blotting and immunogold electron microscopy demonstrated that plasma membrane-derived microvesicles are preferentially enriched in membrane-bound PLY compared to small extracellular vesicles. Consistent with these findings, MVs purified from wild-type PLY-challenged monocytes, fuse with human peripheral blood mononuclear cells, delivering toxin and causing membrane damage, which was significantly lower with the toxoid mutant, PLYW433F. Among PBMCs, CD4+ T cells showed higher PLY positivity upon MV co-incubation and higher cell death compared to monocytes at same dose. Together, our results reveal a noncanonical mode of toxin dissemination, in which vesicle-bound pneumolysin fuses and destabilises target cell membranes, representing an alternative pathway for EV-mediated toxin activity and a potential target for therapeutic intervention.
Frequently asked questions
What did this study find?
Pneumolysin is a pore-forming toxin made by Streptococcus pneumoniae, the bacterium behind most childhood pneumonia. At doses too low to burst a cell outright, host cells respond by patching their membranes and shedding vesicles that carry the toxin away. What those vesicles do next had been unclear. This study combined molecular dynamics simulation, liposome fusion assays and cell experiments to follow toxin-bearing extracellular vesicles. The simulations showed that pneumolysin sitting in a vesicle membrane uses an exposed helix to engage a target membrane, bending it and thinning the bilayer enough to let water through. Confocal imaging and cryo-electron microscopy confirmed that both the toxin and membrane cholesterol drive vesicle-to-membrane fusion. Profiling the vesicles released by challenged monocytes showed that plasma-membrane-derived microvesicles carried more membrane-bound toxin than smaller vesicles. Microvesicles from monocytes exposed to wild-type bacteria fused with human peripheral blood mononuclear cells and damaged them, an effect that was much weaker with a toxoid mutant. Among those immune cells, CD4+ T cells were the most affected.
Was this tested in humans or in the laboratory?
This is preclinical work — the findings come from laboratory models, not from human participants.
Where can I read the original paper?
The full text lives with the publisher: https://doi.org/10.1002/jev2.70387
Does this study prove that JuvGuard works?
No. This is an independent, peer-reviewed study on extracellular vesicles. JuvGuard references the published literature for education only. A single paper cannot establish that any product works, and nothing here is medical advice.
How to cite this paper
Sagilkumar Aswathy C, Kushwaha Avinashi Lal, Shitut Anushka, Sarkar Dheeraj Kumar, Sukumar Sruthika, Mahanty Subhajit et al.. Extracellular Vesicle-Bound Bacterial Toxin Pneumolysin Triggers Membrane Engagement and Damage Beyond Canonical Pore Formation.. Journal of extracellular vesicles. 2026, 2026-09-30. DOI: 10.1002/jev2.70387
Source & verification
- Journal: Journal of extracellular vesicles
- Published: 30 September 2026
- DOI: 10.1002/jev2.70387
- PubMed ID: 42814767
- Indexed via: pubmed
- MeSH terms: Streptolysins, Humans, Streptococcus pneumoniae, Extracellular Vesicles, Cell Membrane, Bacterial Proteins, Molecular Dynamics Simulation, Monocytes, Bacterial Toxins, Liposomes